Related Experiment Video
Updated: Jul 11, 2026
05:07
Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
Open surgery for atherosclerotic chronic mesenteric ischemia
Allan J Kruger1, Philip J Walker, Wallace J Foster
1Department of Vascular Surgery, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia. allanteresa@bigpond.com.au
Journal of Vascular Surgery
|October 2, 2007
Summary
Open surgical mesenteric revascularization offers excellent long-term results for chronic mesenteric ischemia. This study shows low mortality and high graft patency, establishing it as the gold standard treatment.
Area of Science:
- Vascular Surgery
- Gastroenterology
- Interventional Cardiology
Background:
- Chronic mesenteric ischemia (CMI) is a condition requiring revascularization.
- Open surgical mesenteric revascularization is a current treatment modality.
- Comparison with endovascular therapy is increasingly relevant.
Purpose of the Study:
- To document outcomes of open mesenteric revascularization.
- To provide data for comparison with endovascular techniques.
- To evaluate the efficacy of open bypass grafting for CMI.
Main Methods:
- Retrospective review of patients undergoing open mesenteric revascularization (1992-2006).
- Inclusion criteria: CMI secondary to atherosclerosis for ≥3 months.
- Prospective follow-up with clinical assessment and imaging surveillance.
Main Results:
- 41 procedures in 39 patients; mean age 65 years.
- Low perioperative mortality (2.5%) and morbidity (12.2%).
- Excellent 5-year primary graft patency (92%) and favorable long-term outcomes.
Conclusions:
- Open mesenteric revascularization provides low morbidity/mortality and excellent long-term results for CMI.
- It remains the gold standard treatment for most CMI patients.
- Further data on endovascular techniques are needed for definitive comparison.
